Literature DB >> 19218675

Increased levels of interleukin-12 and interleukin-18 in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis.

R M Mroz1, M Korniluk, A Stasiak-Barmuta, E Chyczewska.   

Abstract

We studied prospectively 43 patients with sarcoidosis and 13 normal subjects. IL-12 and IL-18 levels were measured using ELISA kits. Spirometry and body plethysmography were performed using an Elite DL Medgraphics body box. The sarcoidosis group was characterized by significantly higher median range of the plasma angiotensin-converting enzyme (ACE) concentration (72 vs. 34 U/l, P<0.0001), lymphocyte (34 vs. 14%, P<0.0001), CD4+ cells percentages (59 vs. 36%), and CD4/CD8 ratio (4.2 vs. 1.99, P<0.0001). The BALF IL-12 and IL-18 levels were significantly higher in sarcoidosis patients than in healthy subjects (4.1 pg/ml vs. 3.2 pg/ml; P<0.001 and 11.1 pg/ml vs. 6.15 pg/ml, P<0.0001, respectively). A negative correlation between BALF IL-12 and ACE plasma levels (r=-0.33, P<0.05) within the sarcoidosis group was found. Our data suggest a potential role of IL-12 and IL-18 in a local immunologic response in pulmonary sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19218675

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  9 in total

1.  In vitro and in vivo reactivity to fungal cell wall agents in sarcoidosis.

Authors:  M Terčelj; S Stopinšek; A Ihan; B Salobir; S Simčič; B Wraber; R Rylander
Journal:  Clin Exp Immunol       Date:  2011-10       Impact factor: 4.330

Review 2.  The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.

Authors:  Julie H Wu; Sotonye Imadojemu; Avrom S Caplan
Journal:  Am J Clin Dermatol       Date:  2022-05-18       Impact factor: 6.233

3.  Increased levels of Treg cells in bronchoalveolar lavage fluid and induced sputum of patients with active pulmonary sarcoidosis.

Authors:  R M Mroz; M Korniluk; A Stasiak-Barmuta; M Ossolinska; E Chyczewska
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

Review 4.  Sarcoidosis: Immunopathogenesis and Immunological Markers.

Authors:  Wei Sheng Joshua Loke; Cristan Herbert; Paul S Thomas
Journal:  Int J Chronic Dis       Date:  2013-07-25

5.  Fungal exposure and low levels of IL-10 in patients with sarcoidosis.

Authors:  Marjeta Terčelj; Sanja Stopinšek; Alojz Ihan; Barbara Salobir; Saša Simčič; Ragnar Rylander
Journal:  Pulm Med       Date:  2014-08-07

Review 6.  Interleukin-12 family cytokines and sarcoidosis.

Authors:  Sabine Ringkowski; Paul S Thomas; Cristan Herbert
Journal:  Front Pharmacol       Date:  2014-10-27       Impact factor: 5.810

7.  Comparison of serum interleukin-10 level of fungal exposure among patients with pulmonary sarcoidosis and healthy people.

Authors:  Seyed Ali Alavi Foumani; Siamak Geranmayeh; Azita Tangestani Nejad; Aydin Pour Kazemi; Ehsan Kazem Nejad Leili; Alireza Jafari; Mehrzad Amooei Khanabbasi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-09       Impact factor: 0.670

Review 8.  Emerging Molecular Targets for the Treatment of Refractory Sarcoidosis.

Authors:  Gonçalo Boleto; Matheus Vieira; Anne Claire Desbois; David Saadoun; Patrice Cacoub
Journal:  Front Med (Lausanne)       Date:  2020-11-24

9.  Modulatory role of macrophage migration inhibitory factor on cytokines and clinical features of sarcoidosis.

Authors:  Morvarid Elahi; Jaya Talreja; Brennen Steinbauer; Laura L Koth; Lobelia Samavati
Journal:  Sci Rep       Date:  2022-10-07       Impact factor: 4.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.